Visceral obesity is associated with white matter hyperintensity and lacunar infarct

Background:The presence of white matter hyperintensity (WMH) and lacunar infarct are recognized as risk factors of dementia, stroke and mortality. It is undetermined whether visceral adipose tissue (VAT) area is associated with an increased risk of cerebral small vessel disease. We explored whether VAT area was responsible for cerebral small vessel disease through the identification of WMH and lacunar infarct.Subjects:A total of 2046 subjects free of cerebrovascular disease who underwent brain magnetic resonance imaging and abdominal fat computed tomography during a general health check-up were enrolled.Results:The prevalence of cerebral WMH was 37.7%. Subjects with WMH had greater VAT area and higher BMI and waist circumference than those without WMH, although significant differences in subcutaneous adipose tissue (SAT) area were not shown. Subjects with lacunar infarct also had significantly greater VAT area and higher waist circumference and BMI than those without lacunar infarct. Multivariate analyses adjusted for age, sex, diabetes, hypertension, smoking and alcohol, showed VAT area was an independent risk factor of cerebral WMH (odds ratio (OR): 1.13, 95% confidence interval (CI): 1.02–1.24, P=0.016), whereas waist circumference and SAT area were not significantly associated with the risk of WMH. Likewise, VAT area was also independently associated with lacunar infarct (OR: 1.38, 95% CI: 1.06–1.81, P=0.018), whereas the other anthropometric measures were not related with lacunar infarct.Conclusions:VAT has a significant association with cerebral small vessel disease, which was defined as WMH or lacunar infarct. Visceral obesity can be a potential therapeutic target for the prevention of cerebral small vessel disease.

[1]  Robert K. Holzwarth,et al.  Body Fat Distribution as a Risk Factor for Cerebrovascular Disease: An MRI-Based Body Fat Quantification Study , 2013, Cerebrovascular Diseases.

[2]  A Tremblay,et al.  Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. , 1994, The American journal of cardiology.

[3]  P. Deurenberg,et al.  Body mass index and percent body fat: a meta analysis among different ethnic groups , 1998, International Journal of Obesity.

[4]  Bruce M Psaty,et al.  Biomarkers of Inflammation and MRI-Defined Small Vessel Disease of the Brain: The Cardiovascular Health Study , 2008, Stroke.

[5]  P. Scheltens,et al.  White matter hyperintensities, cognitive impairment and dementia: an update , 2015, Nature Reviews Neurology.

[6]  T. Kawanami,et al.  Cerebral small vessel disease and C-reactive protein: Results of a cross-sectional study in community-based Japanese elderly , 2008, Journal of the Neurological Sciences.

[7]  P. Wolf,et al.  Inflammatory biomarkers, cerebral microbleeds, and small vessel disease , 2015, Neurology.

[8]  David G Norris,et al.  Diffusion tensor imaging and cognition in cerebral small vessel disease: the RUN DMC study. , 2012, Biochimica et biophysica acta.

[9]  Chan Soo Shin,et al.  Cerebral white matter hyperintensity is mainly associated with hypertension among the components of metabolic syndrome in Koreans , 2009, Clinical endocrinology.

[10]  I. Lemieux,et al.  Obesity, Inflammation, and Cardiovascular Risk , 2010, Clinical pharmacology and therapeutics.

[11]  J. Meigs,et al.  Links Between Ectopic Fat and Vascular Disease in Humans , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[12]  Jin Hwa Kang,et al.  Nonalcoholic fatty liver disease is associated with coronary artery calcification , 2012, Hepatology.

[13]  J. Chan,et al.  Annals of the New York Academy of Sciences Type 2 Diabetes in East Asians: Similarities and Differences with Populations in Europe and the United States , 2022 .

[14]  A. Berghold,et al.  C-Reactive Protein, Carotid Atherosclerosis, and Cerebral Small-Vessel Disease: Results of the Austrian Stroke Prevention Study , 2006, Stroke.

[15]  J. Trojanowski,et al.  Brain MR: pathologic correlation with gross and histopathology. 2. Hyperintense white-matter foci in the elderly. , 1988, AJR. American journal of roentgenology.

[16]  Jung-Hwan Yoon,et al.  Role of physical activity in nonalcoholic fatty liver disease in terms of visceral obesity and insulin resistance , 2015, Liver international : official journal of the International Association for the Study of the Liver.

[17]  S. Yamaguchi,et al.  C‐reactive protein levels are associated with cerebral small vessel‐related lesions , 2016, Acta neurologica Scandinavica.

[18]  J. Roh,et al.  Dynamics of obesity paradox after stroke, related to time from onset, age, and causes of death , 2012, Neurology.

[19]  A Hofman,et al.  C-Reactive Protein and Cerebral Small-Vessel Disease: The Rotterdam Scan Study , 2005, Circulation.

[20]  Sam K. Y. Sim,et al.  Adverse Associations between Visceral Adiposity, Brain Structure, and Cognitive Performance in Healthy Elderly , 2011, Front. Ag. Neurosci..

[21]  Christian Dehlendorff,et al.  Body mass index and death by stroke: no obesity paradox. , 2014, JAMA neurology.

[22]  S. Anker,et al.  Overweight and obesity are associated with improved survival, functional outcome, and stroke recurrence after acute stroke or transient ischaemic attack: observations from the TEMPiS trial. , 2013, European heart journal.

[23]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[24]  H. Markus,et al.  The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.

[25]  P Zimmet,et al.  Ethnic comparisons of the cross‐sectional relationships between measures of body size with diabetes and hypertension , 2008, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[26]  W. Ryu,et al.  Paradoxical effect of obesity on hemorrhagic transformation after acute ischemic stroke , 2013, BMC Neurology.

[27]  H. Yoshimatsu,et al.  Visceral fat accumulation is a significant risk factor for white matter lesions in Japanese type 2 diabetic patients , 2009, European journal of clinical investigation.

[28]  C. Enzinger,et al.  The natural course of MRI white matter hyperintensities , 2002, Journal of the Neurological Sciences.

[29]  K. Yamashiro,et al.  Visceral fat accumulation is associated with cerebral small vessel disease , 2014, European journal of neurology.

[30]  M. van Buchem,et al.  Visceral adipose tissue is associated with microstructural brain tissue damage , 2015, Obesity.

[31]  H. Jung,et al.  Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case–control study of 7078 Koreans undergoing health check-ups , 2008, Gut.

[32]  P. Deurenberg,et al.  Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship , 2002, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[33]  Philippe Pibarot,et al.  Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[34]  A. Zivelonghi,et al.  Sagittal abdominal diameter as a practical predictor of visceral fat , 1998, International Journal of Obesity.

[35]  Paul Poirier,et al.  Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss: An Update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease From the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism , 2006, Circulation.

[36]  Sang-Heon Cho,et al.  Sagittal Abdominal Diameter Is a Strong Anthropometric Measure of Visceral Adipose Tissue in the Asian General Population , 2010, Diabetes Care.

[37]  M. Elkind,et al.  Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke , 2016, Nature Reviews Neurology.